Simultaneous focal boost with stereotactic radiotherapy for localised intermediate to high-risk prostate cancer: Primary outcomes of the SPARC phase II trial

This study evaluated the toxicity and quality of life (QOL) with CyberKnife-based SBRT and simultaneous integrated boost in localised prostate cancer.

Source: International Journal of Radiation Oncology * Biology * Physics - March 15, 2024 Category: Radiology Authors: Binnaz Yasar, Yae-Eun Suh, Ewan Chapman, Luke Nicholls, Daniel Henderson, Caroline Jones, Kirsty Morrison, Emma Wells, Julia Henderson, Carole Meehan, Aslam Sohaib, Helen Taylor, Alison Tree, Nicholas Van As Tags: Clinical Investigation Source Type: research